➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
McKesson
Express Scripts
Johnson and Johnson
Mallinckrodt
Medtronic

Last Updated: September 26, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Lauromacrogol

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the drug development status for Lauromacrogol?

Lauromacrogol is an investigational drug.

There have been 7 clinical trials for Lauromacrogol. The most recent clinical trial was a Phase 3 trial, which was initiated on May 15th 2020.

The most common disease conditions in clinical trials are Esophageal and Gastric Varices, Hemorrhoids, and Varicose Veins. The leading clinical trial sponsors are West China Hospital, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, and Anhui Provincial Hospital.

There is one US patent protecting this investigational drug and six international patents.

Recent Clinical Trials for Lauromacrogol
TitleSponsorPhase
A Multicenter Prospective Clinical Study of Endoscopic Foam Sclerotherapy for Internal HemorrhoidsAnhui Provincial HospitalPhase 4
A Multicenter Prospective Clinical Study of Endoscopic Foam Sclerotherapy for Internal HemorrhoidsChangzhi People's HospitalPhase 4
A Multicenter Prospective Clinical Study of Endoscopic Foam Sclerotherapy for Internal HemorrhoidsGanzhou Fifth pepole's HospitalPhase 4

See all Lauromacrogol clinical trials

Clinical Trial Summary for Lauromacrogol

Top disease conditions for Lauromacrogol
Top clinical trial sponsors for Lauromacrogol

See all Lauromacrogol clinical trials

US Patents for Lauromacrogol

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Lauromacrogol   Start Trial Compositions and methods for treating chronic inflammation and inflammatory diseases Infirst Healthcare Limited (London, GB)   Start Trial
Lauromacrogol   Start Trial Methods for making low remnant free formaldehyde microcapsules and microcapsules made by same Microtek Laboratories, INC (Dayton, OH)   Start Trial
Lauromacrogol   Start Trial Sewing-free hot melt adhesive TPU leather and preparation method thereof DONGGUAN XIONGLIN NEW MATERIAL TECHNOLOGY CO., LTD (Guangdong, CN)   Start Trial
Lauromacrogol   Start Trial Cosmetic composition comprising an oil, hydrophobic silica aerogel particles and a semi-crystalline polymer L'OREAL (Paris, FR)   Start Trial
Lauromacrogol   Start Trial Amine compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activity Wellstat Therapeutics Corporation (Rockville, MD)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Lauromacrogol

Drugname Country Document Number Estimated Expiration Related US Patent
Lauromacrogol Australia 2011322255 2030-10-29   Start Trial
Lauromacrogol Australia 2012213217 2030-10-29   Start Trial
Lauromacrogol Australia 2012213218 2030-10-29   Start Trial
Lauromacrogol Australia 2014204734 2030-10-29   Start Trial
Lauromacrogol Australia 2014204735 2030-10-29   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
McKesson
Express Scripts
Johnson and Johnson
Mallinckrodt
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.